Diaoyi Tan
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
PEBP4 alleviates muscle wasting in lung cancer cachexia via KEAP1-NRF2-mediated redox homeostasis.
Journal: Cell death & disease
Published: November 17, 2025
Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies.
Journal: Frontiers in immunology
Published: September 28, 2025
UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 09, 2025
Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications.
Journal: Frontiers in cell and developmental biology
Published: July 11, 2025
Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma.
Journal: Cell death and differentiation
Published: March 12, 2025
Identification of the LCOR-PLCL1 pathway that restrains lipid accumulation and tumor progression in clear cell renal cell carcinoma.
Journal: International journal of biological sciences
Published: December 01, 2024
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.
Journal: Cell death & disease
Published: August 29, 2024
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.
Journal: Cell death & disease
Published: March 20, 2024
The PLCG2 Inhibits Tumor Progression and Mediates Angiogenesis by VEGF Signaling Pathway in Clear Cell Renal Cell Carcinoma.
Journal: Frontiers in bioscience (Landmark edition)
Published: January 31, 2024
NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1.
Journal: Cancer communications (London, England)
Published: September 20, 2023
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway.
Journal: Translational oncology
Published: September 14, 2023
HIF2α Promotes Cancer Metastasis through TCF7L2-Dependent Fatty Acid Synthesis in ccRCC.
Journal: Research (Washington, D.C.)
Published: September 12, 2023
Last Updated: 09/26/2026